首页> 美国卫生研究院文献>Frontiers in Physiology >Research Topic: From structural to molecular systems biology: experimental and computational approaches to unravel mechanisms of kinase activity regulation in cancer and neurodegeneration: Efficient computation of minimal perturbation sets in gene regulatory networks
【2h】

Research Topic: From structural to molecular systems biology: experimental and computational approaches to unravel mechanisms of kinase activity regulation in cancer and neurodegeneration: Efficient computation of minimal perturbation sets in gene regulatory networks

机译:研究主题:从结构生物学到分子系统生物学:揭示癌症和神经变性中激酶活性调节机制的实验和计算方法:基因调节网络中最小扰动集的高效计算

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the last few decades, technological and experimental advancements have enabled a more precise understanding of the mode of action of drugs with respect to human cell signaling pathways and have positively influenced the design of new drug compounds. However, as the design of compounds has become increasingly target-specific, the overall effects of a drug on adjacent cellular signaling pathways remain difficult to predict because of the complexity of the interactions involved. Off-target effects of drugs are known to influence their efficacy and safety. Similarly, drugs which are more target-specific also suffer from lack of efficacy because their scope might be too limited in the context of cellular signaling. Even in situations where the signaling pathways targeted by a drug are known, the presence of point mutations in some of the components of the pathways can render a therapy ineffective in a considerable target subpopulation. Some of these issues can be addressed by predicting Minimal Intervention Sets (MIS) of elements of the signaling pathways that when perturbed give rise to a pre-defined cellular phenotype. These minimal gene perturbation sets can then be further used to screen a library of drug compounds in order to discover effective drug therapies. This manuscript describes algorithms that can be used to discover MIS in a gene regulatory network that can lead to a defined cellular phenotype. Algorithms are implemented in our Boolean modeling toolbox, GenYsis. The software binaries of GenYsis are available for download from
机译:在过去的几十年中,技术和实验上的进步使人们对药物相对于人类细胞信号通路的作用方式有了更精确的了解,并积极影响了新药物化合物的设计。但是,由于化合物的设计已变得越来越具有针对性,因此,由于所涉及相互作用的复杂性,药物对相邻细胞信号通路的总体作用仍然难以预测。已知药物的脱靶作用会影响其功效和安全性。类似地,更具靶标特异性的药物也缺乏功效,因为它们的范围在细胞信号转导的情况下可能太受限制。即使在已知药物靶向的信号通路的情况下,在该通路的某些组件中存在点突变也会使治疗在相当大的靶标亚群中无效。这些问题中的某些问题可以通过预测信号传导途径元素的最小干预集(MIS)来解决,该干扰集在受到干扰时会产生预定的细胞表型。然后可以将这些最小的基因扰动集进一步用于筛选药物化合物库,以发现有效的药物疗法。该手稿描述了可用于发现基因调控网络中MIS的算法,可导致定义的细胞表型。算法在我们的布尔建模工具箱GenYsis中实现。可从以下位置下载GenYsis的软件二进制文件

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号